AGO2 and cancer: Hypoxic conditions within cancer cells stimulate EGFR to phosphorylate AGO2 at Tyr393, resulting in decreased AGO2 function that causes decreased DICER–AGO2 interaction, leading to decreased miRNA maturation and function [155].